Cue Share Price

Cue Share Price

NASDAQ: CUE | Small Cap | Healthcare
$4.28
+$1.05 (32.30%) Last updated on 19 Nov, 2026 | 01:26 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Cue Stock Performance

Open
$3.43
Prev. Close
$3.23
Circuit Range
N/A
Day Range
$3.29 - $4.44
Year Range
$0.17 - $45.21
Volume
1,55,815
Average Traded
$3.85

Cue Share Price Today

As of 19 November 2026, Cue Biopharma, Inc.'s share price is $4.28. The stock opened at $3.43, compared to its previous close of $3.23. During today's trading session, Cue Biopharma, Inc.'s share price traded between $3.29 and $4.44, with an average price of $3.87. Over the past 52 weeks, the stock has recorded a high of $45.21 and a low of $0.17. In terms of performance, Cue Biopharma, Inc.'s share price has declined by 80.98% over the last six months and is up 549.47% on a year-on-year basis.

Cue Share Price Chart

Line chart of the Cue price trend over the selected period. The price rose overall, ranging from 3.31 to 4.44, ending at 4.28.
$3.29$4.44
L
Show Current Price
H

Cue Stock Fundamentals & Key Indicators

Market Cap
$405.45M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-22.59
Revenue (TTM)
$27.47B
Return On Equity (TTM)
-7104.24%
Profit Margin
-96.83%
Debt to Equity
0.42
Quarterly Earnings Growth YoY
-1954.63%

Cue Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$2.15$21.94$5.69$7.88
Net Profit-$7.45$1.59-$5.18-$153.07
Net Profit Margin-346.51%7.25%-91.04%-1942.51%
Income ChangeN/A121.34%-425.79%-2855.02%

Cue Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1.25$5.49$9.29$27.47
Net Profit-$53.01-$50.73-$40.67-$26.60
Net Profit Margin-4240.80%-924.04%-437.78%-96.83%
Income ChangeN/A4.30%19.83%34.60%

Cue Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets5.237.0510.0814.1
Current Assets36.9825.1451.4577.19
Total Assets42.2132.1961.5391.28
Non Current Liabilities2.291.07.3614.05
Current Liabilities13.4913.6917.0811.55
Total Liabilities15.7814.6924.4525.6
Shareholders' Equity26.4317.537.0965.68

Cue Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-21.69-36.33-39.96-41.81
Investing0.080.0325.0-24.61
Financing26.2910.2411.8653.66

Corporate Actions

Split
Ex-date: 24 Apr 2026

About Cue

Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.

Cue Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$21.20
$4.33
-78.95%
Oct 2026
$25.54
$20.55
-20.66%
Sep 2026
$25.51
$25.90
-7.47%
Aug 2026
$27.10
$27.99
+2.90%
Jul 2026
$30.45
$27.20
-12.17%
Jun 2026
$23.15
$30.97
+37.64%
May 2026
$33.25
$22.50
+53.06%
Apr 2026
$0.22
$14.70
+6,521.62%
Mar 2026
$0.28
$0.22
-23.18%
Feb 2026
$0.33
$0.29
-14.24%
Jan 2026
$0.32
$0.34
+10.86%
Dec 2025
$0.61
$0.30
-53.87%

Cue Share Price FAQs